Results 101 to 110 of about 25,294 (297)

Efficacy and safety of low-dose everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex [PDF]

, 2020
Takashi Hatano, Katsuhisa Endo, Mayumi Tamari   +2 more
openalex   +1 more source

Activity-promoting gaming systems in exercise and rehabilitation [PDF]

, 2011
Commercial activity-promoting gaming systems provide a potentially attractive means to facilitate exercise and rehabilitation. The Nintendo Wii, Sony EyeToy, Dance Dance Revolution, and Xbox Kinect are examples of gaming systems that use the movement of ...
Griffin, Murray, Impson, Rebecca, McCormick, Darren, Shawis, Teshk, Taylor, Matthew JD   +4 more
core   +1 more source

Recurrent Pneumothorax Revealing Lymphangioleiomyomatosis in a Young Woman: A Case Report

Clinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Lymphangioleiomyomatosis (LAM) should be considered in young women presenting with recurrent pneumothorax. Early diagnosis through high‐resolution computed tomography(HRCT)and histopathological analysis is essential for timely management and improved patient outcomes.
Qihang Zhang, Tianli Zuo, Yongjun He, Wei Zheng   +3 more
wiley   +1 more source

Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.

PLoS ONE, 2017
ObjectivesWe examined the long-term effects of everolimus in patients with renal angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.MethodsFollowing favorable results from the double-blind core phase of EXIST-2
John J Bissler, J Chris Kingswood, Elzbieta Radzikowska, Bernard A Zonnenberg, Elena Belousova, Michael D Frost, Matthias Sauter, Susanne Brakemeier, Petrus J de Vries, Noah Berkowitz, Maurizio Voi, Severine Peyrard, Klemens Budde   +12 more
doaj   +1 more source

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

Journal of Immunotherapy for Cancer, 2018
BackgroundMalignant angiomyolipoma is an uncommon tumor of the class of perivasciular epithelioid cell neoplasms (PEComas). These tumors are characteristically driven by deleterious mutations in the tumor suppressors TSC1 and TSC2, whose gene products ...
Michael Lattanzi, F. Deng, L. Chiriboga, A. Femia, S. Meehan, G. Iyer, M. Voss, Y. Sundatova, W. Huang, A. Balar   +9 more
semanticscholar   +1 more source

Primary soft tissue angiomyolipoma in a dog with unusual clinical features [PDF]

, 2021
Jiří Lenz, Petra Konečná, František Tichý, Luděk Fiala   +3 more
openalex   +1 more source

Advances in the Diagnosis, Treatment, and Management of Liver Nodules: A Comprehensive Review

Portal Hypertension &Cirrhosis, Volume 4, Issue 4, Page 232-251, December 2025.
Liver nodules commonly occur due to various causes, some of which are malignant or may undergo malignant transformation, leading to disease progression or delayed detection in clinical practice. The widespread use of imaging methods has increased the detection rate of liver nodules. Furthermore, precision medicine techniques and artificial intelligence
Chang Gao, Dongyang Chen, Youpeng Chen
wiley   +1 more source

Preoperative radiological characterization of hepatic angiomyolipoma using magnetic resonance imaging and contrast-enhanced ultrasonography: a case report

Journal of Medical Case Reports, 2011
Introduction A hepatic angiomyolipoma is a rare benign tumor of the liver composed of a mixture of smooth muscle cells, blood vessels and a variable amount of adipose tissue.
Schmid Roland M, Gaa Jochen, Lersch Christian, Esposito Irene, Krebs Stephanie, Ebert Oliver   +5 more
doaj   +1 more source

Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy. [PDF]

, 2016
BackgroundEverolimus, an oral mammalian target of rapamycin (mTOR) inhibitor, is used to treat solid tumors and tuberous sclerosis complex (TSC). Stomatitis, an inflammation of the mucous membranes of the mouth, is a common adverse event associated with ...
Anak, O, Franz, D, Gallo, J, Hortobagyi, GN, Motzer, R, Pavel, M, Ravaud, A, Ringeisen, F, Rouyrre, N, Rugo, HS, Yao, J   +10 more
core  

Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial [PDF]

, 2011
This study showed sustained regression of renal angiomyolipomas in patients with tuberous sclerosis or sporadic LAM receiving 2 years of sirolimus treatment.
Cox, J A, Cross, J J, Davies, D M, de Vries, P J, Doyle, T, Howe, C J, Johnson, S R, Kingswood, J C, McCartney, D L, Pointon, K, Sampson, J R, Serra, A L, Tattersfield, A E, Watson, P C   +13 more
core   +1 more source